Search Results 1181-1190 of 17070 for monoclonal antibody
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Neurology Patient Stories. Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody. C.J. Bahnsen. June 2, 2024. Health ...
Description. Immune globulin-dira injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...
... antibody to standard-of-care chemotherapy. “Our hope is that the antibody will neutralize the IL-13 in patients, making pancreatic tumors more susceptible ...
Based on their findings, the research team is proceeding with a phase II clinical trial of the GM-CSF blocking antibody during CAR-T cell therapy. If the trial ...
It almost always starts as a relatively benign condition known as monoclonal gammopathy of undetermined significance (MGUS), which was originally identified at ...
Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...
... antibody-drug conjugate (ADC) for the treatment ... The presence of a monoclonal light chain protein in serum. ... antibody positive), or are positive for HBV ...
Received monoclonal antibodies or had major surgery within 30 days of the first dose of AP26113 (Day 1, Cycle 1). Have been diagnosed with another primary ...
Hydroxychloroquine does not treat coronavirus disease 19 (COVID-19) or prevent infection with the virus that causes COVID-19.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.